<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02484287</url>
  </required_header>
  <id_info>
    <org_study_id>4890</org_study_id>
    <nct_id>NCT02484287</nct_id>
  </id_info>
  <brief_title>Quality Control: A Prospective Analysis of EVD Effectiveness</brief_title>
  <official_title>Quality Control: A Prospective Analysis of External Ventricular Drain (EVD) Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose and/or hypothesis: To decrease the amount of external ventricular drain (EVD)
      related catheter infections by comparing the efficacy of Oklahoma University Medicine
      standard EVD catheters, both impregnated and non-impregnated, in three principle areas:
      incidence of infection, cost analysis, and average durations of placement, all while
      maintaining the standards of technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental design: Track external ventricular drain (EVD) associated infections and through
      quality prospective analysis and compare the usage of standard catheters used by the
      department here at Oklahoma University, 1) the 35cm Codman Bactiseal rifampin and clindamycin
      impregnated catheter, 2) the Ventriclear EVD Antibiotic Catheter, and 3) the 36 cm Integra
      Hermatic large style ventricular catheter, in terms of incidence of infections, cost,
      duration of placement, and differences in placement technique.

      Proposed procedure: Monitor for infections associated with and related to EVD placement in
      patients and assess if infections rates are affected by usage of antibiotic impregnated EVD
      catheters.

      Importance of knowledge reasonably expected to result from the research: While use of sterile
      techniques and periprocedural antibiotics have traditionally been used to combat infection,
      infection rates remain above goal leading to the question of whether the antibiotic
      impregnated catheter should be added to the standard of care. With the knowledge gained, the
      investigators hope to decrease the amount of external ventricular drain related catheter
      infections and reduce use of prolonged antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infection rates of EVD patients</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost comparison between 3 EVDs utilizing data received from billing</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Catheter Related Infections</condition>
  <arm_group>
    <arm_group_label>Integra External Drainage Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ventriclear EVD Antibiotic Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Codman Bactiseal EVD Catheter Set</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The Integra External Drainage Catheter.</intervention_name>
    <description>Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.</description>
    <arm_group_label>Integra External Drainage Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The Ventriclear EVD Antibiotic Catheter</intervention_name>
    <description>Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.</description>
    <arm_group_label>Ventriclear EVD Antibiotic Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The Codman Bactiseal EVD Catheter Set</intervention_name>
    <description>Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.</description>
    <arm_group_label>Codman Bactiseal EVD Catheter Set</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who require placement of external ventricular drain.

        Exclusion Criteria:

          -  Prisoners and/or those who may be pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley Bohnstedt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beverly A Roy, M-HR</last_name>
    <phone>405-271-4912</phone>
    <phone_ext>46011</phone_ext>
    <email>beverly-roy@ouhsc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oklahoma University Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beverly A Roy, M-HR</last_name>
      <phone>405-271-4912</phone>
      <phone_ext>46011</phone_ext>
      <email>beverly-roy@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley Bohnstedt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bohnstedt BN, Ziemba-Davis M, Edwards G, Brom J, Payner TD, Leipzig TJ, Scott JA, DeNardo AJ, Palmer E, Cohen-Gadol AA. Treatment and outcomes among 102 posterior inferior cerebellar artery aneurysms: a comparison of endovascular and microsurgical clip ligation. World Neurosurg. 2015 May;83(5):784-93. doi: 10.1016/j.wneu.2014.12.035. Epub 2014 Dec 23.</citation>
    <PMID>25541085</PMID>
  </reference>
  <reference>
    <citation>Lane B, Bohnstedt BN, Cohen-Gadol AA. A prospective comparative study of microscope-integrated intraoperative fluorescein and indocyanine videoangiography for clip ligation of complex cerebral aneurysms. J Neurosurg. 2015 Mar;122(3):618-26. doi: 10.3171/2014.10.JNS132766. Epub 2014 Dec 19.</citation>
    <PMID>25526265</PMID>
  </reference>
  <reference>
    <citation>Kulwin C, Bohnstedt BN, Payner TD, Leipzig TJ, Scott JA, DeNardo AJ, Cohen-Gadol AA. Aneurysmal acute subdural hemorrhage: prognostic factors associated with treatment. J Clin Neurosci. 2014 Aug;21(8):1333-6. doi: 10.1016/j.jocn.2013.12.010. Epub 2014 Jan 24.</citation>
    <PMID>24679648</PMID>
  </reference>
  <reference>
    <citation>Ziemba-Davis M, Bohnstedt BN, Payner TD, Leipzig TJ, Palmer E, Cohen-Gadol AA. Incidence, epidemiology, and treatment of aneurysmal subarachnoid hemorrhage in 12 midwest communities. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1073-82. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.010. Epub 2013 Oct 19.</citation>
    <PMID>24144595</PMID>
  </reference>
  <reference>
    <citation>Cohen-Gadol AA, Bohnstedt BN. Recognition and evaluation of nontraumatic subarachnoid hemorrhage and ruptured cerebral aneurysm. Am Fam Physician. 2013 Oct 1;88(7):451-6. Review.</citation>
    <PMID>24134085</PMID>
  </reference>
  <reference>
    <citation>Bohnstedt BN, Nguyen HS, Kulwin CG, Shoja MM, Helbig GM, Leipzig TJ, Payner TD, Cohen-Gadol AA. Outcomes for clip ligation and hematoma evacuation associated with 102 patients with ruptured middle cerebral artery aneurysms. World Neurosurg. 2013 Sep-Oct;80(3-4):335-41. doi: 10.1016/j.wneu.2012.03.008. Epub 2012 Mar 30.</citation>
    <PMID>22465372</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2015</study_first_submitted>
  <study_first_submitted_qc>June 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2015</study_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

